Press release
Mumps Vaccine Market is Anticipated to Grow up to USD 3.7 Billion by 2032, Driven by an Increase in the Occurrence of Infectious Diseases | Bavarian Nordic, Astellas Pharma India, CSL Limited
Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS24643
The immunizations used to prevent the mumps virus infection are known as mumps vaccines. The MMR vaccine, which is administered intravenously, is the vaccine of choice to protect against mumps infection. The live attenuated viruses of the three illnesses are used in this injection-based vaccine. Children under the age of 12 months and adults who are not at a high risk of exposure and transmission receive one dose of the MMR vaccination. Children between the ages of 2 and 18 as well as adults who run the risk of contracting the mumps are advised to have two doses of the vaccine.
Read more about Mumps Vaccine Market here: https://www.globalinsightservices.com/reports/mumps-vaccine-market/
Market Driver & Trends
Due to the large number of customers who are health-conscious, the pharmaceutical sector is growing and innovating to produce vaccines, which opens up opportunities for the mumps vaccine market to expand. The availability of increasing healthcare infrastructure, an increase in unmet healthcare demands, an increase in the occurrence of infectious diseases like the mumps diseases, and a surge in demand for mumps vaccines are all predicted to contribute to the growth of the mumps vaccine market.
Furthermore, the desire for better healthcare services, considerable government investments in enhancing the infrastructure for healthcare, and the growth of the medical tourism sector in emerging nations are all contributing to the significant growth of the global market for measles vaccines.
Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS24643
Global Mumps Vaccine Market Segmentation
By Age Group
• Pediatric
• Adult
By Distribution Channel
• Hospitals & Clinics
• Vaccination Centers
By Region
• North America
o The U.S.
o Canada
o Mexico
• Europe
o The UK
o Germany
o France
o Spain
o Rest of Europe
• The Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Rest of the World
o Latin America
o The Middle East
o Africa
Purchase This Market Research Report - https://www.globalinsightservices.com/checkout/single_user/GIS24643
Major Players in the Global Mumps Vaccines Market
The key players studied in the report are MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, and GlaxoSmithKline among others.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mumps Vaccine Market is Anticipated to Grow up to USD 3.7 Billion by 2032, Driven by an Increase in the Occurrence of Infectious Diseases | Bavarian Nordic, Astellas Pharma India, CSL Limited here
News-ID: 3151567 • Views: …
More Releases from Global Insight Services
Liver Disease Treatment Market: Expansion Fueled by Increasing Incidence of NAFL …
The Liver Disease Treatment Market continues to expand rapidly as global awareness, early diagnosis, and advanced therapeutic approaches reshape patient care. With the market valued at $26.6 billion in 2024 and projected to reach $44.8 billion by 2034 at a steady 5.4% CAGR, demand for effective and accessible therapies is on the rise. The Liver Disease Treatment Market covers pharmaceuticals, biologics, vaccines, diagnostics, and liver transplant services designed to manage…
Healthcare Supply Chain BPO Market: Expansion Fueled by Increasing Outsourcing o …
The Healthcare Supply Chain BPO Market is rapidly evolving as healthcare providers worldwide seek smarter, leaner, and more resilient operations. With growing pressure to reduce costs, boost efficiency, and maintain uninterrupted patient care, outsourcing supply chain tasks has become a strategic necessity. The global Healthcare Supply Chain BPO Market is projected to grow from $3.05 billion in 2024 to $4.83 billion by 2034, reflecting a CAGR of 4.7%. This expansion…
Robotics Crawler Camera System Market Rise by 2034 | Key Players: Inuktun Servic …
Market Overview
Robotics Crawler Camera System Market is witnessing a major transformation as industries shift toward advanced inspection technologies that improve safety, accuracy, and operational efficiency. These robotic crawlers, equipped with high-resolution cameras and strong maneuverability, enable real-time inspection across pipelines, sewers, industrial tanks, and hazardous environments where manual inspections pose risks. As automation becomes central to industrial maintenance, the Robotics Crawler Camera System Market continues to gain momentum, supported by…
Pet DNA Testing Market Growth to 2034 | Key Players: Wisdom Panel, Embark Veteri …
Market Overview
Pet DNA Testing Market is rapidly transforming the way pet owners understand the health, ancestry, and traits of their companion animals. As pets increasingly become family members, owners are demanding deeper insights into their pets' genetic makeup. The Pet DNA Testing Market offers services such as breed identification, disease risk assessments, trait analysis, and ancestry mapping. With advancements in genomics and the expansion of direct-to-consumer testing kits, the Pet…
More Releases for Mumps
Global Measles Mumps And Rubella Mmr Vaccines Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Measles Mumps And Rubella Mmr Vaccines market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for measles, mumps, and rubella (MMR) vaccines is steadily expanding as a result of growing vaccination campaigns and greater…
Mumps Vaccine Market Expected to Reach $3.5 Billion by 2031
Mumps vaccine is the most efficient way of preventing mumps viral infection in children and elderly population. Mumps vaccine is mainly administered in the form of combination vaccine, which offers resistance against measles, mumps, and rubella virus infections. The vaccine has no side effects; however, some cases may encounter very mild fever or rash. In addition, in some pediatric patients, mumps vaccine is given in the form of MMRV vaccine,…
Mumps Vaccine Market Boosting Technologies, Industry Growth, Demand Status, Tren …
Measles, Mumps, and Rubella (MMR) vaccinations are a mixture of live viruses that are injected. The live viruses are inactivate and cannot reproduce in human cells while the immune system responds and defends against the infection. The MMR vaccine has a long-term effect. The MMR vaccine causes fever, rash, cough, body pain, headache, nausea and severe consequences such as ovaries and testicles infection, deafness, and in rare cases it leads…
Measles, Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2026 – …
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as…
Mumps Market Estimated to Flourish by 2016 – 2024 : Persistence Market Researc …
Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands. The disease is transmitted from one person to the other through saliva and/or droplets. Although the symptoms vanish within few days of infection and are usually…
Mumps - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Mumps - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H1 2017, provides an overview of the Mumps (Infectious Disease) pipeline landscape.
Mumps is a contagious disease that leads to painful swelling of the salivary glands. The mumps are caused by a virus.…
